HEADER IMMUNE SYSTEM 26-OCT-04 1XUO TITLE X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 1,4-DIAZEPANE-2,5-DIONE TITLE 2 INHIBITOR AT 1.8A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRIN ALPHA-L; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: I-DOMAIN; COMPND 5 SYNONYM: LEUKOCYTE ADHESION GLYCOPROTEIN LFA-1 ALPHA CHAIN, LFA-1A, COMPND 6 LEUKOCYTE FUNCTION ASSOCIATED MOLECULE 1, ALPHA CHAIN, CD11A; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET17B KEYWDS I-DOMAIN, INTEGRIN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR S.WATTANASIN,J.KALLEN,S.MYERS,Q.GUO,M.SABIO,C.EHRHARDT,R.ALBERT, AUTHOR 2 U.HOMMEL,G.WECKBECKER,K.WELZENBACH REVDAT 4 20-MAR-24 1XUO 1 COMPND SOURCE REVDAT 3 25-OCT-23 1XUO 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1XUO 1 VERSN REVDAT 1 26-OCT-05 1XUO 0 JRNL AUTH S.WATTANASIN,J.KALLEN,S.MYERS,Q.GUO,M.SABIO,C.EHRHARDT, JRNL AUTH 2 R.ALBERT,U.HOMMEL,G.WECKBECKER,K.WELZENBACH,G.WEITZ-SCHMIDT JRNL TITL 1,4-DIAZEPANE-2,5-DIONES AS NOVEL INHIBITORS OF LFA-1 JRNL REF BIOORG.MED.CHEM.LETT. V. 15 1217 2005 JRNL REFN ISSN 0960-894X JRNL PMID 15686945 JRNL DOI 10.1016/J.BMCL.2004.11.072 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.9999 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 35097 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1844 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2452 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2120 REMARK 3 BIN FREE R VALUE SET COUNT : 108 REMARK 3 BIN FREE R VALUE : 0.2500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2866 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 246 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.27000 REMARK 3 B22 (A**2) : -0.75000 REMARK 3 B33 (A**2) : 0.48000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.126 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.118 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.076 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.374 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2969 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2681 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4001 ; 1.283 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6275 ; 0.773 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 352 ; 5.734 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 134 ;35.889 ;25.299 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 544 ;13.227 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;16.618 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 449 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3221 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 603 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 526 ; 0.205 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2479 ; 0.172 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1522 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 172 ; 0.144 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 15 ; 0.174 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 37 ; 0.286 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.144 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2292 ; 1.246 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 724 ; 0.187 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2864 ; 1.391 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1451 ; 2.210 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1137 ; 3.120 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1XUO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-OCT-04. REMARK 100 THE DEPOSITION ID IS D_1000030782. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-00 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.80000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35097 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06700 REMARK 200 FOR THE DATA SET : 29.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40000 REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: 1CQP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, HEPES, PH 7.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.12950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.30800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.99750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.30800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.12950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.99750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL ASSEMBLY IS CHAIN A (OR CHAIN B) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 124 REMARK 465 ALA A 125 REMARK 465 SER A 126 REMARK 465 LYS A 127 REMARK 465 ILE A 309 REMARK 465 GLU A 310 REMARK 465 GLY A 311 REMARK 465 MET B 124 REMARK 465 ALA B 125 REMARK 465 SER B 126 REMARK 465 LYS B 127 REMARK 465 GLN B 303 REMARK 465 LYS B 304 REMARK 465 LYS B 305 REMARK 465 ILE B 306 REMARK 465 TYR B 307 REMARK 465 VAL B 308 REMARK 465 ILE B 309 REMARK 465 GLU B 310 REMARK 465 GLY B 311 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 290 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP B 156 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 174 -107.30 -145.95 REMARK 500 LYS A 190 37.51 39.88 REMARK 500 LEU A 204 -139.36 -123.04 REMARK 500 LEU A 205 -156.24 -95.69 REMARK 500 SER B 174 -101.64 -147.18 REMARK 500 LEU B 204 -138.02 -124.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 312 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 139 OG REMARK 620 2 SER A 141 OG 90.0 REMARK 620 3 ASP A 239 OD1 90.6 82.1 REMARK 620 4 GLU A 301 OE2 85.8 90.7 171.9 REMARK 620 5 HOH A 402 O 172.2 90.5 97.2 86.4 REMARK 620 6 HOH A 403 O 87.2 162.6 80.8 106.2 94.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 312 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 404 O REMARK 620 2 HOH A 405 O 85.6 REMARK 620 3 SER B 139 OG 178.0 93.2 REMARK 620 4 SER B 141 OG 87.0 92.7 91.6 REMARK 620 5 ASP B 239 OD1 88.0 172.8 93.1 83.7 REMARK 620 6 HOH B 313 O 94.4 98.5 87.3 168.8 85.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 312 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 312 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LA1 A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CQP RELATED DB: PDB REMARK 900 RELATED ID: 1XDD RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH LFA703 AT 2.2A RESOLUTION REMARK 900 RELATED ID: 1XDG RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH LFA878 AT 2.1A RESOLUTION DBREF 1XUO A 127 311 UNP P20701 ITAL_HUMAN 152 336 DBREF 1XUO B 127 311 UNP P20701 ITAL_HUMAN 152 336 SEQADV 1XUO MET A 124 UNP P20701 CLONING ARTIFACT SEQADV 1XUO ALA A 125 UNP P20701 CLONING ARTIFACT SEQADV 1XUO SER A 126 UNP P20701 CLONING ARTIFACT SEQADV 1XUO TRP A 189 UNP P20701 ARG 214 SEE REMARK 999 SEQADV 1XUO MET B 124 UNP P20701 CLONING ARTIFACT SEQADV 1XUO ALA B 125 UNP P20701 CLONING ARTIFACT SEQADV 1XUO SER B 126 UNP P20701 CLONING ARTIFACT SEQADV 1XUO TRP B 189 UNP P20701 ARG 214 SEE REMARK 999 SEQRES 1 A 188 MET ALA SER LYS GLY ASN VAL ASP LEU VAL PHE LEU PHE SEQRES 2 A 188 ASP GLY SER MET SER LEU GLN PRO ASP GLU PHE GLN LYS SEQRES 3 A 188 ILE LEU ASP PHE MET LYS ASP VAL MET LYS LYS LEU SER SEQRES 4 A 188 ASN THR SER TYR GLN PHE ALA ALA VAL GLN PHE SER THR SEQRES 5 A 188 SER TYR LYS THR GLU PHE ASP PHE SER ASP TYR VAL LYS SEQRES 6 A 188 TRP LYS ASP PRO ASP ALA LEU LEU LYS HIS VAL LYS HIS SEQRES 7 A 188 MET LEU LEU LEU THR ASN THR PHE GLY ALA ILE ASN TYR SEQRES 8 A 188 VAL ALA THR GLU VAL PHE ARG GLU GLU LEU GLY ALA ARG SEQRES 9 A 188 PRO ASP ALA THR LYS VAL LEU ILE ILE ILE THR ASP GLY SEQRES 10 A 188 GLU ALA THR ASP SER GLY ASN ILE ASP ALA ALA LYS ASP SEQRES 11 A 188 ILE ILE ARG TYR ILE ILE GLY ILE GLY LYS HIS PHE GLN SEQRES 12 A 188 THR LYS GLU SER GLN GLU THR LEU HIS LYS PHE ALA SER SEQRES 13 A 188 LYS PRO ALA SER GLU PHE VAL LYS ILE LEU ASP THR PHE SEQRES 14 A 188 GLU LYS LEU LYS ASP LEU PHE THR GLU LEU GLN LYS LYS SEQRES 15 A 188 ILE TYR VAL ILE GLU GLY SEQRES 1 B 188 MET ALA SER LYS GLY ASN VAL ASP LEU VAL PHE LEU PHE SEQRES 2 B 188 ASP GLY SER MET SER LEU GLN PRO ASP GLU PHE GLN LYS SEQRES 3 B 188 ILE LEU ASP PHE MET LYS ASP VAL MET LYS LYS LEU SER SEQRES 4 B 188 ASN THR SER TYR GLN PHE ALA ALA VAL GLN PHE SER THR SEQRES 5 B 188 SER TYR LYS THR GLU PHE ASP PHE SER ASP TYR VAL LYS SEQRES 6 B 188 TRP LYS ASP PRO ASP ALA LEU LEU LYS HIS VAL LYS HIS SEQRES 7 B 188 MET LEU LEU LEU THR ASN THR PHE GLY ALA ILE ASN TYR SEQRES 8 B 188 VAL ALA THR GLU VAL PHE ARG GLU GLU LEU GLY ALA ARG SEQRES 9 B 188 PRO ASP ALA THR LYS VAL LEU ILE ILE ILE THR ASP GLY SEQRES 10 B 188 GLU ALA THR ASP SER GLY ASN ILE ASP ALA ALA LYS ASP SEQRES 11 B 188 ILE ILE ARG TYR ILE ILE GLY ILE GLY LYS HIS PHE GLN SEQRES 12 B 188 THR LYS GLU SER GLN GLU THR LEU HIS LYS PHE ALA SER SEQRES 13 B 188 LYS PRO ALA SER GLU PHE VAL LYS ILE LEU ASP THR PHE SEQRES 14 B 188 GLU LYS LEU LYS ASP LEU PHE THR GLU LEU GLN LYS LYS SEQRES 15 B 188 ILE TYR VAL ILE GLU GLY HET MG A 312 1 HET LA1 A 401 40 HET MG B 312 1 HETNAM MG MAGNESIUM ION HETNAM LA1 (2R)-2-[3-ISOBUTYL-2,5-DIOXO-4-(QUINOLIN-3-YLMETHYL)-1, HETNAM 2 LA1 4-DIAZEPAN-1-YL]-N-METHYL-3-(2-NAPHTHYL)PROPANAMIDE HETSYN LA1 (S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL- HETSYN 2 LA1 [1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL- HETSYN 3 LA1 PROPIONAMIDE FORMUL 3 MG 2(MG 2+) FORMUL 4 LA1 C33 H36 N4 O3 FORMUL 6 HOH *246(H2 O) HELIX 1 1 GLN A 143 LEU A 161 1 19 HELIX 2 2 ASP A 182 LYS A 190 1 9 HELIX 3 3 ASP A 191 LEU A 196 1 6 HELIX 4 4 ASN A 207 VAL A 219 1 13 HELIX 5 5 ARG A 221 GLY A 225 5 5 HELIX 6 6 ILE A 248 LYS A 252 5 5 HELIX 7 7 LYS A 263 GLN A 266 5 4 HELIX 8 8 THR A 267 LEU A 274 1 8 HELIX 9 9 HIS A 275 PHE A 277 5 3 HELIX 10 10 PRO A 281 PHE A 285 1 5 HELIX 11 11 GLU A 293 GLN A 303 1 11 HELIX 12 12 LYS A 304 ILE A 306 5 3 HELIX 13 13 GLN B 143 LEU B 161 1 19 HELIX 14 14 ASP B 182 LYS B 190 1 9 HELIX 15 15 ASP B 191 LEU B 196 1 6 HELIX 16 16 ASN B 207 VAL B 219 1 13 HELIX 17 17 ARG B 221 GLY B 225 5 5 HELIX 18 18 ILE B 248 LYS B 252 5 5 HELIX 19 19 LYS B 263 GLN B 266 5 4 HELIX 20 20 THR B 267 THR B 273 1 7 HELIX 21 21 LEU B 274 ALA B 278 5 5 HELIX 22 22 PRO B 281 PHE B 285 1 5 HELIX 23 23 THR B 291 GLU B 293 5 3 HELIX 24 24 LYS B 294 GLU B 301 1 8 SHEET 1 A 6 TYR A 177 PHE A 181 0 SHEET 2 A 6 TYR A 166 PHE A 173 -1 N GLN A 172 O LYS A 178 SHEET 3 A 6 VAL A 130 ASP A 137 1 N PHE A 134 O VAL A 171 SHEET 4 A 6 THR A 231 THR A 238 1 O ILE A 235 N LEU A 135 SHEET 5 A 6 ILE A 255 ILE A 261 1 O ILE A 259 N ILE A 236 SHEET 6 A 6 VAL A 286 LEU A 289 1 O LEU A 289 N GLY A 260 SHEET 1 B 6 TYR B 177 PHE B 181 0 SHEET 2 B 6 TYR B 166 PHE B 173 -1 N ALA B 170 O GLU B 180 SHEET 3 B 6 VAL B 130 ASP B 137 1 N PHE B 134 O VAL B 171 SHEET 4 B 6 THR B 231 THR B 238 1 O VAL B 233 N VAL B 133 SHEET 5 B 6 ILE B 255 ILE B 261 1 O ILE B 259 N ILE B 236 SHEET 6 B 6 VAL B 286 LEU B 289 1 O LYS B 287 N ILE B 258 LINK OG SER A 139 MG MG A 312 1555 1555 2.16 LINK OG SER A 141 MG MG A 312 1555 1555 2.03 LINK OD1 ASP A 239 MG MG A 312 1555 1555 2.18 LINK OE2 GLU A 301 MG MG A 312 3545 1555 2.05 LINK MG MG A 312 O HOH A 402 1555 1555 2.09 LINK MG MG A 312 O HOH A 403 1555 1555 2.02 LINK O HOH A 404 MG MG B 312 1555 1555 2.10 LINK O HOH A 405 MG MG B 312 1555 1555 2.12 LINK OG SER B 139 MG MG B 312 1555 1555 2.20 LINK OG SER B 141 MG MG B 312 1555 1555 2.07 LINK OD1 ASP B 239 MG MG B 312 1555 1555 2.09 LINK MG MG B 312 O HOH B 313 1555 1555 2.06 CISPEP 1 LYS A 280 PRO A 281 0 -2.25 CISPEP 2 LYS B 280 PRO B 281 0 6.53 SITE 1 AC1 6 SER A 139 SER A 141 ASP A 239 GLU A 301 SITE 2 AC1 6 HOH A 402 HOH A 403 SITE 1 AC2 6 HOH A 404 HOH A 405 SER B 139 SER B 141 SITE 2 AC2 6 ASP B 239 HOH B 313 SITE 1 AC3 10 PHE A 153 TYR A 166 TYR A 257 LEU A 302 SITE 2 AC3 10 LYS A 305 ILE A 306 VAL A 308 HOH A 486 SITE 3 AC3 10 MET B 140 LEU B 203 CRYST1 46.259 59.995 142.616 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021617 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016668 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007012 0.00000